FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to stable solid medication, containing olmesartan medoxomil and amlodipine or its pharmaceutically acceptable salt. Said solid medication is, in fact, free of reducing sugars. Stable solid medication optionally can additionally contain hydrochlortiazide or its pharmacologically acceptable salt. Medicinal form is intended for treatment or prevention of diseases caused by hypertension.
EFFECT: solid medicinal form in accordance with invention has improved solubility properties in comparison with lactose-containing composition.
42 cl, 2 dwg, 4 tbl, 2 ex
